Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.

about

Specific inhibition of CK2α from an anchor outside the active site LncRNA MEG3 Regulates Imatinib Resistance in Chronic Myeloid Leukemia via Suppressing MicroRNA-21.Therapeutic targeting of CK2 in acute and chronic leukemias.

P2860

Q38815725-33ECA9DD-23F6-417F-942D-FAF9F6FEC158 Q41498465-8E4E921F-9B88-424F-A274-5274C8ED86CB Q47677919-EDC58613-F6F4-4A66-BF06-4DAF9DA6554B

P2860

Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.

Item

http://www.wikidata.org/entity/Q42412981

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Inhibition of protein kinase C ...... mbined therapeutic strategies.

@en

Inhibition of protein kinase C ...... mbined therapeutic strategies.

@nl

type

Item

label

Inhibition of protein kinase C ...... mbined therapeutic strategies.

@en

Inhibition of protein kinase C ...... mbined therapeutic strategies.

@nl

prefLabel

Inhibition of protein kinase C ...... mbined therapeutic strategies.

@en

Inhibition of protein kinase C ...... mbined therapeutic strategies.

@nl

P1476

Inhibition of protein kinase C ...... ombined therapeutic strategies

@en

P2093

Arianna Donella-Deana

http://www.w3.org/2001/XMLSchema#string

Lorenzo A Pinna

http://www.w3.org/2001/XMLSchema#string

Luca Cesaro

http://www.w3.org/2001/XMLSchema#string

Valentina Salizzato

http://www.w3.org/2001/XMLSchema#string

P2860

The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation

Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony

Signal transduction in the chronic leukemias: implications for targeted therapies

RETRACTED: Nuclear Extracellular Signal-Regulated Kinase 1 and 2 Translocation Is Mediated by Casein Kinase 2 and Accelerated by Autophosphorylation

Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer

TOR signaling in growth and metabolism

Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks

Nuclear export of S6K1 II is regulated by protein kinase CK2 phosphorylation at Ser-17

mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events

Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells

P304

18204-18218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.7569

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christian Borgo

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26919095

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

leukemia

P932

4951282

http://www.w3.org/2001/XMLSchema#string

Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.

about

P2860

P2860

Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932